Analysis of Normal and Infected Bio-Cell Using Dual Nanoprobe

来源 :Energy Science and Technology | 被引量 : 0次 | 上传用户:xiaojia1118
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
   Abstract
  The objective of this paper is to analyze the yeast cell, liver cell and blood cell under both infected and healthy conditions by applying electrical signal through dual nanoprobe from source to cell. Knowledge of nanoprobe based bio-cell analysis can be used to differentiate infected cells from healthy ones, since their electrical behaviour is different. The voltage can be applied either inside the cytoplasm penetrating the cell wall, or at the outer surface of cell membrane. In this paper, the simulation has been carried out by applying voltage inside the cytoplasm using ABAQUS 6.10 CAE, powerful finite element software and the results obtained from simulation shows current flow healthy yeast and dead yeast cells are 1·9nA and 34pA respectively whereas the value of the current measured for the leukaemia affected blood cell is 21·2nA, being 2% less than the White Blood Cell (WBC). Since the conductivity of the cytoplasm of the healthy cell is theoretically higher than that of dead or infected cell, which is verified by simulation. The results from simulation show that the measured cell current from liver tumour cell is 2-7 times larger than healthy liver cell including membrane as it is supposed to be since the conductivity of cell including cell membrane is theoretically greater for dead or infected cell than healthy cell.
  Key words: Dual nanoprobe; Cell viability test; Yeast cell; WBC; Liver cell; Axon cell; ECD; ABAQUS 6.10 CAE; Electrical conductivity
   INTRODUCTION
  Nanoprobe based bio-cell analysis method introduces the cell analysis in nanotechnology, a new field of science. In the analytical procedure, a single cell is analysed by measuring the current through the cell by the application of a dc voltage using dual nanoprobe. ABAQUS 6.10 CAE, powerful finite element software has been used to carry out the simulation. Figure 1 shows schematic diagram of penetration of dual nanoprobe into the cell. Figure 2 shows only contact of dual nanoprobe with cell membrane.
  Among various electrical behaviours shown by biocell, two are taken into account for cell analysis. One is conductivity of cytoplasm and another is conductivity of the cell including cell membrane.




  The cytoplasm conductivity of cancerous or infected cell is lower than that of healthy cell. Because when the cell is dead or cancerous, the ions concentrations become lower than healthy cell (Ingebrandt, 2007). On the other hand, the conductivity of cell including membrane shows higher conductivity in case of cancerous or infected cell than that of healthy one, because when the cell becomes cancerous the permeability of the cell increases causing more current to flow into the cell. (Steve Haltiwanger, Sahu, 2005; Tandon, 2012). The membrane composition in cancer cells gets altered and higher permeability results in movement of K, Mg and Ca out of the cell. The accumulation of Na and water results in flowing of more into the cell, hence current is higher.   The conventional method of cell viability and cancer detection is done by using chemical substances (Sulaiman, 2012). Colorimetric or florescent dyes are used for cell viability detection. The limitation of this method is the lack of capability to produce instantaneous and quantitative result but nanoprobe based cell analysis method is much better in terms of producing instantaneous and quantitative result (Sulaiman, 2012).
  Bone marrow aspiration is a conventional type of biopsy used to diagnose leukemia. In open biopsy, the bone is taken out and stiches are given to the patient for which he may experience bleeding and has to stay at hospital. Nanoprobe testing provides better method for leukemia detection.
   1. METHODOLOGY
  For the purpose of analysis a dual nanoprobe is needed to apply electrical power to the bio-cell. From Figure 1 the one end of nanoprobe has to be connected with 2V dc source and the other ends of nanoprobe have to be penetrated into the cell wall for both yeast and blood cell (Figure 1) or have to be in close contact with the cell membrane for liver cell(Figure 2). When power supply is switched on a current flow occurs through the cell. The power is supplied only for 0.1 second to protect the cell from damage.


  1.1 Experimental Method
  The cell is analyzed with ESEM-Nano-manipulator System shown in Figure 3. The output current is measured by Sub-femto ampere source meter and the analog current value is converted into digital by data acquisition (DAQ). This digital data is then represented by graphical user interface (GUI) system.


   2. SIMULATION PROCEDURE
  For the purpose of simulation ABAQUS 6.10 CAE(Computer Aided Engineering) software is used that provides strong platform to design and simulate any type. It has the ability for use in nano-scale level simulation.
  The major part of the study is to characterize the nanoprobe based on the types of material, cross sectional area and length of probes. Resistance of the probe is one of the most important factors. Among different materials which can be used for the construction of the probe, the material with low resistance and no chemical reaction effect on the cell is the best choice. The size of nanoprobe used for simulation is 15μm long and 200nm x 200nm cross-sectional area and the probe is made of gold. Different mechanical and electrical properties are given to gain a model, which is seemed to be as close as real cell.    3. SIMULATION RESULTS
  The current flow through the cells is represented by Electric Current Density (ECD) shown in Figure 6. The output current is found by the product of average crosssectional area of cell and average electrical current density(ECD) value.
  I=ResultantECD×A
  Where, I = Current, A = Cross-sectional Area of cell.
  Figure 5 represents the electric current density (ECD) for different cell model. The resultant ECD magnitudes are 268pA/μm2, 4.8pA/μm2, 162.6pA/μm2, 443.4pA/μm2, 3.037nA/μm2 and 3.0nA/μm2 for healthy, dead, normal liver, liver tumor, white blood and leukemia affected white blood cells respectively in Figure 6.


  By using resultant ECD magnitudes from Figure 6 a current that flows through the cell can be drawn from (1).
  From Figure 7(a) the current values are 1.9nA and 34pA for healthy and dead cells, from Figure 7(b), 1.1486nA and 3.1327nA for liver and liver tumor cells and from Figure 7(c) 21.457nA and 21.2nA for WBC and leukemia affected WBC.






  3.1 Probe Gap
  The simulation has been carried out for five different gap distances. Table 1 shows the results of the simulation for each gap distance and its corresponding current value for Normal WBC, Leukemia affected WBC, Healthy Yeast Cell, and dead Yeast cell. Fixed variables are the material for the probe and the penetration depth of probe into the cell. Figure 8 shows different probe gap.




  Figures 9 and 10 both are representing the value of current for healthy and dead yeast cell and for WBC and leukemia affected WBC at different probe gap.
  From the results obtained in simulation, the relationship between the probe gap and current is uncertain, because of various contact area between the cell and the probe. The cell has uneven surface which affect the contact area with the probe and the probe tip, being unable to provide a constant contact area with the cell. Hence, re-designing the probes to make them sharp to the point could provide better results, which is very difficult to fabricate.    CONCLUSION
  Table 2 and table 3 show the comparison among experimental data, simulation result obtained from reference paper and present simulation done in this analysis. The probe gap was taken 1.46μm for penetration.


  Sensitivity is considered as linear function for this simulation. This simulation result is 9.3 times sensitive of experimental result and is more accurate than the results obtained from reference paper. The test may give perfect result if the cells are tested in same environment, keeping same probe gap and same depth of penetration because the conductivity between probes across the cell may vary with probe gap, depth of penetration and environmental condition surrounding the cell. More than one sample of blood cell having WBC should be tested for better confirmation of the presence of immature WBC as the conductivity difference between normal WBC and leukemia affected WBC is only 2%.


  This dual Nano probe based analytical process may have better opportunities, when it will be practically implemented. For detection of healthy, death and cancerous cells (leukemia), this process may give instantaneous and better results. This project is only a small portion of a big idea. Simulation is one of the universal approaches that researchers use in their research. This novel nanoprobe based detection process may introduce with versatile opportunities for researchers and a revolutionary change can occur in medical science especially in the section of detection, analysis and treatment of diseases.
   ACKNOWLEDGMENTS
  All eulogize to Allah the Almighty, the most genial, most gracious, and most munificent. We would like to acknowledge Dr. Muhammad Ahsan Ullah for his constant support and guidance. We would also like to express heartily gratitude toward our friend Habib Titas, for giving us guidance and providing the Finite Element Analysis software for our research.
   REFERENCES
  Ahmad, M.R., Nakajima, M., Fukuda, T., Kojima S., & Homma, M. (2009). In Proceedings of the Single Cells Electrical Characterizations using Nanoprobe via ESEMNanomanipulator System, Genoa, 26-30 July 2009 (pp. 589-292). IEEE Xplore.
  Cone C.D. (1970). Variation of the transmembrane potential level as a basic mechanism of mitosis control. Oncology, 24(6), 438-470.
  Cure J.C. (1991). Cancer an electrical phenomenon. Resonant.   Ingebrandt, S., Wrobel, G., Eick, S., Schafer, S., & Offenhausser A. (2007) Probing the Adhesion and Viability of Individual Cells with Field-Effect Transistors. In Proceedings of the Solid-State Sensors, Actuators and Microsystems Conference, Lyon, 10-14 June 2007(pp. 803-806). IEEE Xplore.
  Sahu, R.K., Zelig, U., Huleihel, M., Brosh, N., Talyshinsky, M., Ben-Harosh, M., Mordechai, S., & Kapelushnik, J.(2005). Continuous monitoring of WBC (biochemistry) in an adult leukemia patient using advanced FTIR-spectroscopy. Leukemia Research, 30(6), 687-693.
  Steve Haltiwanger M.D., C.C.N,. The Electrical Properties of Cancer Cell. Retrieved from website: http://www.royalrife. com/haltiwanger1.pdf.
  Sulaiman, A.H.M. (2012). Modeling and simulation of Novel Method of Cell Viability Detection via Electrical Measurement using Dual Nanoprobes. In Proceedings of the Enabling Science and Nanotechnology (ESciNano), Johor Bahru, 5-7 Jan 2012 (pp. 1-2). IEEE Xplore.
  Tandon, T. (2012). Novel Detection of Hematological Cancer: A Proposed Conductivity Based Analysis for Early Leukemia Cell Identification. California, USA.
其他文献
E:作为免疫学方面的国际知名专家,是什么契机让您选择了回国发展?  廖化新:坦白讲,同国内相比,我在美国能得到的各项支持都是世界一流的,包括经费和科研条件。因此当时有很多人希望我不要放弃那么好的资源,应该既保持资源,又能为国家做些事情。但我觉得如果不踏实来做,这件事情我就做不好。实际上回到国内也得到了非常良好的政府层面支持,比如珠海市政府为我们提供了场地,广东省创新团队也给了我们3000万元的支持
期刊
孙飘扬 恒瑞医药董事长  新药审批周期长依然是阻碍研发的因素,而且目前审批的科学性也有待研究。这两年来国家大力推动审评审批改革,确实也发生比较大的变化,半年左右就能够获得临床批件,但现在实行的审评审批政策是以解决前一阶段积压为目标,能否常态化还并不确定。此外对于CFDA来说,当前无论是审评审批制度还是审评人员的数量和质量都还没有跟国际接轨,对审评审批制度科学性方面的诸多问题重视程度不够。其次是适用
期刊
徐希平 奥萨医药总裁  事实上我们在新药的研究中,临床研究的投入将近总费用三分之二。在临床研究上进行大量资金投入的意义,我的理解是,如果只重视临床前研究,而缺乏临床研究和循证医学研究,中国的创新药走向世界很难。事实上在欧美上市的新药非常多,而真正能够做成重磅炸弹的、对临床上被广大患者和医生所欢迎的并不多。缺乏临床研究,就抓不住目标市场人群,不足以满足临床需求。  我们做化学药,一定要和中国的人群特
期刊
在第八届中国医药企业家年会最后一场“药品监管与创新”政策专题讨论会上,国家食品药品监督管理总局(CFDA)药品审评中心(以下简称药审中心)主任许嘉齐说:“我认为在科学上面不能用行政的方式去简单地改变人们,应该允许在科学上不断地互相质疑,用数据来达成共识,从而防范风险,这可能是更好的科学方法。”  堵车  时间推至两年前,关于中国药品审评速度太慢的抱怨几乎会一直盘旋在药审中心位于北京玉渊潭南路的白色
期刊
对于国内众多CRO企业来说,过去的一年颇不平静。“7·22”风暴宣示着临床试验数据自查核查工作的正式开始,1622个在总局待审的申请项目要依照GCP要求对临床试验情况开展自查,以确保临床试验数据的真实可靠。核查严格之程度,史上无出其右。  但这也是CRO春风得意的开始。仿制药质量与疗效一致性评价工作的开展,给CRO行业带来了史无前例的发展机遇,数百亿元的纯增量市场即将开放。但能否在遍地黄金中发现机
期刊
2016年10月30日,由E药经理人杂志承办的第八届中国医药企业家年会,组织了一场延续一整天的重要分论坛—17个优秀创新项目路演,吸引了上百位来自产业界及投资界的各路精英。  第八届中国医药企业家年会的目标是通过搭建沟通平台,引导新历史阶段下的投资与合作,打造出中国版“JP摩根健康大会”。  优秀医药创新项目的路演毫无疑问成为此次大会的重头戏。17个创新项目,经过层层筛选,分别涉及医学及精准医疗、
期刊
企业家才是经济发展的国王。企业家们无限挑战自己的思想和人性,永不停息地奋斗,真正以患者为中心,大苦难大担当。  2016年5月至今,E药经理人先后组织了100余名医药企业家走进华为公司,学习华为的精神和实战。这是医药行业历史性的一次对标中国本土最具竞争力的世界级标杆企业大学习。中国医药行业必将诞生华为式的世界级企业。  在2016年10月28~30日,聚集了千余位中国医药行业企业家和精英翘楚的第八
期刊
这是一个遍地黄金的时代。越来越多的中国本土医药企业正尝试出海淘金,投资并购动作不断,业务版图扩张频繁。  但这仍是一个充满挑战的时代。我们试图走出去,但最后发现难成规模;我们试图引领创新,但最终发现仍难言成功。中国药企在世界舞台上仍缺乏足够的话语权,这是一个让中国本土医药企业家心有不甘却又无可奈何的事实,也是整个医药行业的现实焦虑。  但在另一个领域,我们看到一个中国民营企业正如火箭般速度迅速崛起
期刊
如果要评选2016年度国内医药市场最关注的话题,医保目录调整一定是其中一个重要选项。9月30日,人社部公布了2016年版的“医保调整方案”,而此时距上一版全国医保目录调整已过去了七年之久。医保目录将会如何变化?自家企业能否从中获益?这是所有国内医药企业的聚焦点所在。  此前东方证券发布数篇报告,就医保目录调整给本土医药企业带来的机遇与挑战做出了详尽分析,而在第八届中国医药企业家年会上,东方证券组织
期刊
10月28日,借着中国版“J.P摩根大会”第八届中国医药企业家年会召开的契机,筹备完善的“中国医疗健康产业投资50人论坛”首届执委会正式成立,并召开第一次会议。这意味着作为中国版“J.P摩根大会”的重要一环,中国医药企业家年会吸引了投资机构的深入参与。  我国的“十三五”规划纲要,将“健康中国战略”纳入其中。有机构预计,“十三五”期间围绕大健康、大卫生和大医学的健康医疗产业规模有望达到10万亿元量
期刊